Protocol for Alpha MSH Infusion Study in Patients With Type 2 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

March 4, 2024

Primary Completion Date

April 4, 2024

Study Completion Date

April 4, 2024

Conditions
Type 2 Diabetes Mellitus
Interventions
OTHER

α-MSH infusion

Pharmaceutical grade α-MSH is custom synthesized to GMP standards by Auspep (Australia www.auspep.com.au), a good manufacturing practice (GMP) accredited manufacturer of peptides, approved by the Therapeutic Goods Administration (TGA), European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA).

OTHER

Placebo solutions

Pharmaceutical GMP-grade sterile 0.5% human albumin dissolved in saline.

Trial Locations (1)

Unknown

RECRUITING

Dasman Diabetes Institute, Kuwait City

All Listed Sponsors
lead

Dasman Diabetes Institute

OTHER